Exhibit
4.14


 


	[Stamp]
                                            State of Israel

    Israeli
    Medical Cannabis Agency

    (IMCA)
	[logo]
                                            [emblem of the State of Israel

    Ministry
    of Health

    [illegible]

    Medical
    Cannabis Agency
	 

     

     

    Valid
    until: October 20, 2022

    Dealer’s
    Code: V-1315-060518



 


Initial
Authorization to Establish a Site for Dealing with a Controlled Substance


 


By
virtue of the authority vested in me pursuant to Sections 6, 7 and 13 in the middle of the Dangerous Drugs Ordinance


[New
Version], 5733 – 1973 (hereinafter “the Ordinance”) and pursuant to the Dangerous Drugs Regulations, 5739 – 1979
(hereinafter: “the Regulations”), an initial authorization is hereby granted to establish a proliferation farm – proliferation
of cannabis plants (hereinafter “the site”) and, according to the following detail:


 


	1.	The
                                            Applicant for the Authorization and his Details:



 





	 	1.1

        

        
	Name
                                            of the entrepreneur/Corporation: Dalia Bezizinsky

    

    
	 	

    ID/Co
    No: 054771613: (hereinafter: “the applicant”)

    

    

	 	1.2	Site
    Address: Kochav Michael	 	Farm/Estate:
    Form Number 10
	 	1.3	Contact
    Person (Name): Dalia Bezizinsky	 	ID
    No: 054771613 Tel No: 054-222-8861


 


	2.	Name
                                            of the Controlled Substance






 


CANNABIS


 


	3.	Its
                                            Form



 


This
approval does not constitute approval for possession in any form It is
absolutely prohibited to possess the drug, plant, any part of it, its components or products and in any form for as long as no express
license for this is been received from the Director.


 


	4.	The
                                            Purpose of the Approval



 


		4.1	To
                                            act for planning/establishing/adapting a proliferation farm – proliferation of
                                            the cannabis plant
		4.2	The
                                            applicant declares that this approval will not be used for any purpose not approved and specified
                                            expressly in this approval.



 


		5.	Restrictions
                                            and Additional Conditions:



 


		5.1	This approval
    is only temporary. This approval can be annulled pursuant to the Director’s sole discretion, or pursuant to a Government of
    Israel decision, without derogating from any other cause in the law for annulling the approval.
		5.2	This approval
    contains nothing to impose any obligation whatsoever on the Ministry of Health or the Medical Cannabis Agency to grant a license
    for dealing in a controlled substance.
		5.3	This approval
    is approval for the applicant to commence establishing or adapting the site pursuant to the designated occupation. The principles
    of the planning and establishment/adaptation of the business must be executed pursuant to the designated occupation, while complying
    with all the relevant requirements of the law and pursuant to quality and security requirements as detailed below:
			a.	Cultivation
                                            or proliferation of the cannabis plants – as detailed in Procedure IMC-GAP (proper
                                            cultivation conditions) and as detailed in Procedure IMC GSP (security conditions).



 


It
must be emphasized: The applicant must comply with the security requirements as detailed in Procedure IMC-GSP at the site and must receive
security approval pursuant to the type of occupation.


 


		5.4	This
                                            approval cannot be transferred in any form whatsoever.
		5.5	Should
                                            there be any change whatsoever in the ownership of the applicant, or in the identity of the
                                            controlling shareholders therein, or in its managers or authorized signatories, who are detailed
                                            in this license without receiving the advance written approval of the IMCA for this –
                                            the validity of the license will expire. Regarding this section, a change in the ownership
                                            means transferring shares, in any manner whatsoever, in a volume that exceeds 5% of the Company’s
                                            total share capital.




 


[signature]


[stamp]
MGR Yuval Landschaft


L.N.
4023


Director


the
Medical Cannabis Agency (IMCA)


	Israel
                                            Medical Cannabis Agency

    Minister
    Health

    PO
    Box 1176 Jerusalem 91010

    IMCA@moh.health.gov.il

    Tel
    No *5400 Fax No: 02-647-4810
	Kol
                                            Habriut

    *5400
	[bilingual
    text see left column]


 




    	 



     


    

 


	[Stamp]
                                            State of Israel

    Israeli
    Medical Cannabis Agency

    (IMCA)
	[logo]
                                            [emblem of the State of Israel

    Ministry
    of Health

    [illegible]

    Medical
    Cannabis Agency
	 

     

     

    Valid
    until: October 20, 2022

    Dealer’s
    Code: V-1315-060518



 


		5.6	In
                                            view of the activity in the cannabis field, and because this activity obligates, inter alia,
                                            receipt of the IMCA’s approval for all the dealers, managers and interested parties
                                            in companies and/or their managers – granting the initial authorization/the license
                                            is subject to the attached conditions:



 


	 	a.	Any
    material shareholder as defined in the Company’s capital, 5759 – 1999 and/or controlling shareholder as defined in the
    Company’s capital 5759 – 1999 and/or any effective controlling shareholder and/or Director and/or General Manager in
    the Company, has to receive the IMCA’s approval.
	 	b.	No
    shares in the Company may be transferred to any offeree whatsoever when, following this allocation, he will become an interested
    party, prior to the IMCA’s approval for this after receiving a recommendation from a competent official.
	 	c.	No
    Director and/or General Manager may be appointed in the Company prior to receiving the IMCA’s approval for this, after receiving
    a recommendation from a competent official. This
	 	d.	The
    Company must amend its Articles of Association so that they include an instruction pursuant to which if any entity/entities whatsoever
    becomes/become an interested party/interested parties in the Company by virtue of his/their shareholding or an agreement between
    the shareholders, prior to receiving the mandatory approvals from the IMCA, the Company shall have the right to confiscate and/or
    make some of the shares held by one or more of these shareholders dormant so that after the confiscation and/or making the shares
    dormant the entity/entities will no longer be interested parties by virtue of the holdings or by virtue of agreement in the Company.
	 	 	d1.	An
    entity/entities, whose shares have been made dormant, should they be made dormant, shall, at any time, have the right to sell or
    transfer all or some of these shares to another/others, subject to the details in this Procedure and the requirements of the Ordinance
    and the Law.
	 	e.	The
    Company will not extend the appointment of a Director or its General Manager, unless at the date of the extension there is approval
    from the IMCA in this regard, after receiving a repeat recommendation from a competent official.
	 	f.	At
    every Annual Meeting of the Company, the General Manager of the Company must declare that all the approval/approvals required from
    the IMCA for the Company, the manager/managers and the interested party/parties, as detailed in Sections a, b, and c above as at
    the date of the meeting, are available and valid and there has not been any change in the status of the Company, the managers/managers,
    material shareholder/shareholders and the interested party/parties from the date of being granted the authorization/authorizations


 


	 	5.7	The
    applicant must inform the Director immediately of any change in any of his details (his address, contact persons etc.) and must receive
    the IMCA’s advance written approval for any change in the ownership of the applicant or in the identity of the interested parties
    or its managers or its authorized signatories or the material shareholders.
	 	5.8	The
    presence of minors at the site or installation is absolutely prohibited.
	 	5.9	The
    instructions in the ordinance and regulations and any instruction and/or stipulation for complying with any of the quality conditions
    required shall apply to the applicant.
	 	5.10	The
    applicant must keep a regular record of all the actions regarding the establishment of the site and any additional record required
    by the Director.
	 	 	The
    records must be presented to the Director whenever he requires this and must also be presented to any other competent entity according
    to the matter pursuant to the demand of the Director.
	 	5.11	These
    conditions and stipulations can be updated at the IMCA’s sole discretion and with approval of the Director General of the Ministry
    of Health. The IMCA is entitled to publish additional instructions pursuant to the circumstances and essence of the occupation.


 


[signature]


[stamp]
MGR Yuval Landschaft


L.N.
4023


Director


the
Medical Cannabis Agency (IMCA)


	Israel
                                            Medical Cannabis Agency

    Minister
    Health

    PO
    Box 1176 Jerusalem 91010

    IMCA@moh.health.gov.il

    Tel
    No *5400 Fax No: 02-647-4810
	Kol
                                            Habriut

    *5400
	[bilingual
    text see left column]


 




    	 



     


    

 


	[Stamp]
                                            State of Israel

    Israeli
    Medical Cannabis Agency

    (IMCA)
	[logo]
                                            [emblem of the State of Israel

    Ministry
    of Health

    [illegible]

    Medical
    Cannabis Agency
	 

     

     

    Valid
    until: October 20, 2022

    Dealer’s
    Code: V-1315-060518



 


	6.	The
                                            Validity of the Approval



 


	 	6.1	This
    approval annuls any other or additional previous approval in the possession of the applicant.
	 	6.2	This
    approval was granted on October 20, 2021 at the offices of the IMCA
	 	6.3	The
    validity of this approval expires on October 20, 2022, unless it is annulled previously to this at the decision of
    the Director.


 


Yuval
Landschaft


The
Director pursuant to the Dangerous Drugs Ordinance


 


[signature]


[stamp]
MGR Yuval Landschaft


L.N.
4023


Director


the
Medical Cannabis Agency (IMCA)


	Israel
                                            Medical Cannabis Agency

    Minister
    Health

    PO
    Box 1176 Jerusalem 91010

    IMCA@moh.health.gov.il

    Tel
    No *5400 Fax No: 02-647-4810
	Kol
                                            Habriut

    *5400
	[bilingual
    text see left column]